Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.

Germline genetic testing, previously restricted to familial and young-onset breast cancer, is now offered increasingly broadly to patients with 'population-type' breast cancer in mainstream oncology clinics, with wide variation in the genes included.